Mineralys Therapeutics, Inc. announced it raised $118 Million in an initial filing from an offering of $118 Million

Jun 13, 2022•over 3 years ago

Amount Raised

$118 Million

RadnorBiotechnology Research

Company Information

Company

Mineralys Therapeutics, Inc.

Location

150 N. RADNOR CHESTER ROAD

Radnor, Pennsylvania, United States

About

At Mineralys Therapeutics we aim to redefine hypertension diagnosis, management and treatment. We are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of hypertension.

Related People

1 contact

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Mineralys Therapeutics, Inc. announced it raised $118 Million in an initial filing from an offering of $118 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information